The theory that pruritus from cholestasis is due to increased opiate tone appears to have merit, based on the results of the clinical trials presented above. However, although opioid antagonists ...
Hosted on MSN2mon
Mirum Shares Surge More Than 90% in 6 Months: Here's WhyIn March 2024, the FDA approved Livmarli for the treatment of cholestatic pruritus in patients aged five years and older with progressive familial intrahepatic cholestasis (PFIC), a rare genetic ...
The treatment is for cholestatic pruritus—skin itching caused by the slowing of bile movement from the liver. Write to Emily Dattilo at [email protected] Shares of Incyte were spiraling ...
04 November 2022 The topic was re-considered by the Topic Selection Oversight Panel (TSOP) in September 2022. The panel concluded that the topic should remain routed to the Technology Appraisal (TA) ...
GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver ... patients with cholestatic pruritus (relentless itch).
(Nasdaq: MIRM) today announced that on 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement ...
It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the U.S. three months of age and older and in Europe for patients two months of age and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback